207 WEST 25TH ST, 9TH FLOOR, NEW YORK, NY
Amendment No. 5 to Securities Purchase Agreement Executed by Profusa, Inc.
Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with a Commercial Stage Diagnostics Company
Announces 1-for-4 Reverse Stock Split
Press Release Dated July 27, 2026
Announces 1-for-25 Reverse Stock Split
Stockholders Elect Lauren Chung as Class I Director at Special Meeting
Other Events
Annual Report to Security Holders
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Notice of Late Filing for Quarterly Report
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload